Skip to main content
OpenTrials
Completed

NCT Number: NCT04240678

The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening

Asian and Pacific Islander Americans at risk, but never tested for chronic hepatitis B have been randomized to receive an electronic alert in their electronic medical chart to remind primary care physicians to screen them for chronic hepatitis B.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Asian and Pacific Islanders (API) who have not yet received HBsAg testing. API will be identified using a novel algorithm which identifies them using their surname, language preference, country of origin.

-

Exclusion criteria

Previous HBsAg completion.

-

Treatment and study plan

Electronic HBV Alert

Other

Electronic HBV Alert deployed in electronic medical charts of at risk patients

Primary outcomes

  1. Serum Hepatitis B Surface Antigen Completion

    Time frame: up to 12 months

    Number of patients who have completed the HBsAg test

Secondary outcomes

  1. Serum Hepatitis B Surface Antigen Positivity

    Time frame: up to 12 months

    Number of patients with testing positive for HBsAg

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Registry information

Official study title

The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening: A Randomized Controlled Trial

Important dates

Study start
2016
Primary completion
2019
Study completion
2021
First posted
Jan 27, 2020
Registry last updated
Aug 11, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.